
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
beta 2 Sodium Potassium ATPase/ATP1B2 CRISPR/Cas9 KO Plasmid (h) | sc-410695 | 20 µg | $397.00 | |||
beta 2 Sodium Potassium ATPase/ATP1B2 HDR Plasmid (h) | sc-410695-HDR | 20 µg | $445.00 |
ATP1B2 encodes the β2 subunit of the Na⁺/K⁺-ATPase, a plasma membrane ion pump complex essential for maintaining Na⁺ and K⁺ gradients that support membrane potential, osmotic balance, and secondary active transport. Beyond ion homeostasis, ATP1B2 contributes to pump assembly and trafficking and can influence cell adhesion and signal transduction linked to MAPK and PI3K/AKT pathway activity. In human tissues, ATP1B2 is highly relevant to excitable cell physiology and neuronal function, where altered Na⁺/K⁺-ATPase composition can perturb synaptic signaling and cellular resilience to stress. Dysregulation of Na⁺/K⁺-ATPase subunits has been associated with neurodevelopmental and neurodegenerative phenotypes and may also affect tumor cell behavior through changes in ionic microenvironment and downstream signaling.
beta 2 Sodium Potassium ATPase/ATP1B2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ATP1B2 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the ATP1B2 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, beta 2 Sodium Potassium ATPase/ATP1B2 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined ATP1B2 target site.
When co-transfected with beta 2 Sodium Potassium ATPase/ATP1B2 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the ATP1B2 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.